Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
about
Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature reviewA critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorderBinding of Sulpiride to Seric Albumins.Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.Augmentation of olanzapine in treatment-resistant schizophrenia.Incorporating clinical guidelines through clinician decision-making.Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.Relationship between estrogen and schizophrenia.Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective DisorderClozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.Management of schizophrenia in children and adolescents: focus on pharmacotherapy.Antipsychotic polypharmacy in schizophrenia: benefits and risks.Antipsychotic combinations for schizophrenia.Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date.Ziprasidone as adjunctive therapy in severe bipolar patients treated with clozapine.Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis.The successful concurrent use of two long-acting depot antipsychotics in a patient with treatment-resistant schizophrenia and history of serious violence: a case report.Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
P2860
Q24598636-FCC1E061-3F47-45C8-9F88-8F9F8F20D316Q26766541-B0D703CA-4AD9-4188-B5A4-7D48ED51BB99Q30383282-224D60EE-9F26-480A-A747-F865AF2306CFQ30981989-CA1A1FD3-094A-4ADB-99BF-F9CEB0A2107DQ35771833-414D4073-8692-48A1-AE05-83A5E10E80CBQ36331244-0A889BF6-C631-41E7-ABD1-52EC9B1DC5DDQ36535311-77E6C117-B9B5-4157-A587-AEAE0FD77EF2Q36648481-97CE322A-5F9A-4EB4-928E-D2549FECDF44Q36691761-E5D32A15-A6AA-493E-8D73-60F07607680EQ37063242-80F8E689-7689-4CE8-A11B-25337B264635Q37097619-8232C511-E4C2-4865-96AF-6BD32C30C79EQ37833061-4F9212C0-FDBD-48FE-8180-FA2BABE70721Q37863093-D0BEF160-C996-4CC9-B72B-3B6A739A0C69Q38704394-BB77CB49-F0FA-4344-89C6-72C38B4BDAE8Q38770356-1E39431D-4EA9-40FC-91D1-5E9AD00F2380Q39037156-9404160B-B0B2-433F-832C-8EA0610EF900Q43679387-30AB6C7E-A584-43AE-A99F-164E13223CF9Q47870089-154EBD93-07CF-4B7C-B863-CD3AA421CC03Q50804521-C356DCDC-C1D1-4FEB-BA38-DE21085613CDQ58768772-3CEDC659-19C5-4EED-933F-BA55BA50C89C
P2860
Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Combination of "atypical" anti ...... and schizoaffective disorder.
@ast
Combination of "atypical" anti ...... and schizoaffective disorder.
@en
type
label
Combination of "atypical" anti ...... and schizoaffective disorder.
@ast
Combination of "atypical" anti ...... and schizoaffective disorder.
@en
prefLabel
Combination of "atypical" anti ...... and schizoaffective disorder.
@ast
Combination of "atypical" anti ...... and schizoaffective disorder.
@en
P2093
P1476
Combination of "atypical" anti ...... and schizoaffective disorder.
@en
P2093
Igor Libov
Moshe Kotler
Rael D Strous
Vladimir Lerner
P356
10.1016/J.PNPBP.2003.09.024
P577
2004-01-01T00:00:00Z